Guardion Health Sciences ... (GHSI)
OTC: GHSI
· Real-Time Price · USD
3.22
0.00 (0.00%)
At close: Mar 06, 2025, 3:00 PM
Guardion Health Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 72.92K | 3M | 2.94M | 3.34M | 2.79M | 3.19M | 2.73M | 2.66M | 3.28M | 2.38M | 2.63M | 3.15M | 1.22M | 233.3K |
Cost of Revenue | 36.57K | 1.82M | 1.59M | 1.88M | 1.54M | 1.85M | 1.79M | 1.58M | 1.88M | 1.29M | 1.56M | 1.76M | 665.22K | 133.01K |
Gross Profit | 36.35K | 1.18M | 1.34M | 1.46M | 1.25M | 1.34M | 936.2K | 1.09M | 1.4M | 1.1M | 1.06M | 1.39M | 558.5K | 100.28K |
Operating Income | -1.38M | -1.02M | -692.2K | -772.91K | -1.01M | -1.46M | 6.44M | -1.74M | -1.71M | -2.6M | -14.52M | -3.02M | -4.54M | -2.67M |
Interest Income | 117.25K | 75.64K | 90.24K | 94.75K | 95.53K | 99K | 98.11K | 43.28K | 9.62K | 1.56K | 849.00 | 682.00 | 266.00 | n/a |
Pretax Income | -2.13M | -4.75M | 424.72K | 372.63K | -1.17M | 533.09K | -8.91M | -1.7M | -1.7M | -2.62M | -14.52M | -3.01M | -4.54M | -2.67M |
Net Income | 10.32M | -4.75M | 424.72K | 372.63K | -1.17M | 2.53M | -24.25M | -1.7M | -1.7M | -2.64M | -14.52M | -3.01M | -4.54M | -2.67M |
Selling & General & Admin | 1.4M | 2.2M | 2.04M | 2.22M | 2.18M | 2.74M | 2.19M | 2.76M | 3.02M | 3.69M | 3.73M | 4.08M | 2.98M | 2.75M |
Research & Development | n/a | 3.17K | 80.00 | 10.67K | 77.2K | 62.73K | 31.38K | 60.2K | 95.52K | 6.69K | 10.76K | 16.23K | 16.76K | 20.61K |
Other Expenses | 13.86K | n/a | n/a | n/a | n/a | n/a | 10.08M | n/a | n/a | n/a | 14.26M | n/a | 1.44M | n/a |
Operating Expenses | 1.42M | 2.2M | 2.04M | 2.23M | 2.26M | 2.8M | 2.22M | 2.82M | 3.11M | 3.69M | 3.74M | 4.09M | 3M | 2.77M |
Interest Expense | n/a | n/a | 2M | n/a | n/a | n/a | 15.34M | n/a | n/a | 1.56K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 8.09K | 361.91K | 372.21K | 318.73K | 415.08K | 598.65K | 486.31K | 526.19K | 388.51K | 668.64K | 570.25K | 777.53K | 440.79K | 457.73K |
Cost & Expenses | 1.45M | 4.02M | 3.63M | 4.11M | 3.8M | 4.65M | 4.01M | 4.39M | 4.99M | 4.98M | 5.3M | 5.85M | 3.66M | 2.9M |
Income Tax Expense | n/a | 1.00 | 2.98M | -1.15M | 159.76K | -2M | 15.34M | -33.99K | 5.36M | 22.7K | -14 | n/a | n/a | -5 |
Shares Outstanding (Basic) | 1.28M | 1.28M | 1.28M | 1.27M | 1.27M | 1.27M | 1.27M | 1.23M | 1.23M | 783.02K | 1.22B | 488.54K | 488.54K | 427.03K |
Shares Outstanding (Diluted) | 1.28M | 1.28M | 1.28M | 1.27M | 1.27M | 1.27M | 1.27M | 1.23M | 1.23M | 783.02K | 1.22B | 488.54K | 488.54K | 427.03K |
EPS (Basic) | 8.04 | -3.71 | 0.33 | 0.29 | -0.93 | 2.00 | -19.13 | -1.38 | -1.38 | -3.37 | -0.01 | -6.17 | -9.29 | -6.25 |
EPS (Diluted) | 8.04 | -3.71 | 0.33 | 0.29 | -0.93 | 2.00 | -19.13 | -1.38 | -1.38 | -3.37 | -0.01 | -6.17 | -9.29 | -6.25 |
EBITDA | -1.36M | -1.39M | -687.3K | -768.02K | -1.42M | -1.46M | -981.19K | -1.42M | -1.39M | -2.28M | -14.19M | -2.39M | -2.32M | -2.65M |
EBIT | -1.37M | -1.02M | -692.21K | -772.91K | -1.42M | -1.38M | -1.28M | -1.73M | -1.71M | -2.6M | -14.52M | -2.7M | -2.44M | -2.67M |
Depreciation & Amortization | 4.57K | 4.79K | 4.9K | 4.9K | 4.83K | 4.79K | 302.39K | 312.22K | 317.13K | 317.05K | 333.01K | 357.76K | 160.44K | 59.17K |